Share chart Edgewise Therapeutics, Inc.
Extended chart
Simple chart
About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc., биофармацевтическая компания, разрабатывает низкомолекулярные препараты для лечения заболеваний опорно-двигательного аппарата. Ведущий продукт-кандидат компании, EDG-5506, представляет собой малую молекулу для перорального введения, предназначенную для устранения основной причины дистрофинопатий, включая мышечную дистрофию Дюшенна и мышечную дистрофию Беккера, которая завершила первую фазу клинических испытаний. more details| IPO date | 2021-03-26 |
|---|---|
| ISIN | US28036F1057 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.edgewisetx.com |
| Цена ао | 22.26 |
| Change price per day: | 0% (11.42) |
|---|---|
| Change price per week: | -3.47% (11.83) |
| Change price per month: | -54.83% (25.28) |
| Change price per 3 month: | -54.92% (25.33) |
| Change price per half year: | -65.38% (32.99) |
| Change price per year: | -30.7% (16.48) |
| Change price per 3 year: | +34.04% (8.52) |
| Change price per year to date: | -61.95% (30.01) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Orbimed Advisors LLC. | 14567176 | 15.65 |
| FMR, LLC | 6492513 | 6.97 |
| Viking Global Investors, L.P. | 6159146 | 6.61 |
| Novo Holdings A/S | 6071703 | 6.52 |
| Deerfield Management Company, L.P. (Series C) | 3933137 | 4.22 |
| EcoR1 Capital, LLC | 3493194 | 3.75 |
| Blackrock Inc. | 3307110 | 3.55 |
| Baker Brothers Advisors, LLC | 3112786 | 3.34 |
| Frazier Life Sciences Management, L.P. | 2667203 | 2.86 |
| Citadel Advisors Llc | 2585930 | 2.78 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Future Tech ETF | 0.25784 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.25784 | 618.5 | 0.8416 |
| 0.26 | 522.42 | 0.84 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Kevin Koch Ph.D. | President, CEO & Director | 913.1k | 1960 (65 years) |
| Dr. Badreddin Edris Ph.D. | Co-Founder & Independent Director | 40k | 1987 (38 years) |
| Dr. Behrad Derakhshan Ph.D. | Chief Business Officer | 575.53k | 1980 (45 years) |
| Dr. Joanne M. Donovan M.D., Ph.D. | Chief Medical Officer | 695.48k | 1957 (68 years) |
| Dr. Alan J. Russell Ph.D. | Co-Founder, Chief Scientific Officer & Director | 657.52k | 1970 (55 years) |
| Mr. R. Michael Carruthers | Chief Financial Officer | 386.01k | 1958 (67 years) |
| Mr. John R. Moore | General Counsel | N/A | 1964 (61 year) |
| Dr. Marc Semigran M.D. | Chief Development Officer | N/A | 1957 (68 years) |
| Dr. Peter A. Thompson FACP, M.D. | Co-Founder & Independent Chairman | 73k | 1960 (65 years) |
Address: United States, Boulder. CO, 3415 Colorado Avenue - open in Google maps, open in Yandex maps
Website: https://www.edgewisetx.com
Website: https://www.edgewisetx.com
